Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Paeds SAQsrheumatology-musculoskeletal-and-sports

Paeds SAQs · rheumatology-musculoskeletal-and-sports

Primary immunodeficiency with rheumatic manifestations — formative SAQs

Formative SAQs on recognising the rheumatic-immune overlaps that earn an immune work-up (CVID with symmetric polyarthritis and autoimmune cytopenia, CGD with Crohn-like granulomatous colitis, classical complement deficiency with childhood-onset lupus, and Blau syndrome), confirming each with its matched test, and treating both the immune defect and the rheumatic manifestation in parallel while deferring immunosuppression and live vaccines until the immune screen is back.

20 marks30 min
On this page & tools

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE

Target exams

RACP General PaediatricsMRCPCH ClinicalRACP DWE
Prompt
Primary immunodeficiency with rheumatic manifestations

SAQ 1 (10)

A six-year-old girl presents with a three-month symmetric polyarthritis of the wrists and knees that has been labelled juvenile idiopathic arthritis. Over the same period she has had two pneumonias, chronic diarrhoea, and bruising from a platelet count of 40 × 10⁹/L. Her total IgG is well below the age-adjusted reference range. Her pneumococcal vaccine response is poor. [7] [8]

a) What is the most likely underlying diagnosis, and why does the combination of arthritis with recurrent infection, chronic diarrhoea, and autoimmune thrombocytopenia point to it rather than to ordinary juvenile idiopathic arthritis? (3 marks) [3]

b) Justify why immunoglobulin replacement alone is unlikely to control her arthritis and thrombocytopenia, and outline the principle that should govern their management. (3 marks) [7]

c) Outline the further investigations needed to characterise the cellular defect and to exclude secondary causes before committing to a lifelong label. (2 marks) [1]

d) Discuss the principles of long-term management, including the hazard of starting a biologic before the immune screen is complete, lung surveillance, and the disposition between immunology and rheumatology. (2 marks) [3]

SAQ 2 (10)

An eight-year-old boy has a granulomatous colitis with perianal disease that is indistinguishable from Crohn disease on biopsy, but he has also had a staphylococcal liver abscess and a Serratia pneumonia. Separately, a five-year-old boy presents with systemic lupus erythematosus, nephritis, a family history of lupus and meningococcal disease, and a total haemolytic complement (CH50) that is persistently absent when checked well. [4] [9]

a) For the first child, name the most likely underlying immune defect and the single confirmatory test. Explain why the organism cluster (Staphylococcus, Serratia) and the granulomatous colitis point to it. (3 marks) [4]

b) Explain why treating this child's colitis with immunosuppression before the confirmatory test is dangerous, and outline the principles of management including prophylaxis and the role of haematopoietic stem cell transplantation. (3 marks) [5]

c) For the second child, identify the likely category of diagnosis, explain the mechanism by which classical complement deficiency produces childhood-onset lupus, and justify why the CH50 must be checked when the child is well rather than during a flare. (2 marks) [9] [10]

d) Describe the additional prevention that classical complement deficiency requires beyond standard lupus therapy, and the family-screening implications. (2 marks) [9]

References

  1. [1]Bousfiha A, Moundir A, Tangye SG, et al. The 2022 Update of IUIS Phenotypical Classification for Human Inborn Errors of Immunity. J Clin Immunol, 2022.PMID 36198931
  2. [3]Köstel Bal S, Pašmandi J, Bhatta B, Boztug K. Rheumatological manifestations in inborn errors of immunity. Pediatr Res, 2020.PMID 31581173
  3. [4]Winkelstein JA, Marino MC, Johnston RB Jr, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore), 2000.PMID 10844935
  4. [5]Kang EM, Marciano BE, DeRavin S, et al. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J Allergy Clin Immunol, 2011.PMID 21497887
  5. [7]Odnoletkova I, Kindle G, Quinti I, et al. The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data. Orphanet J Rare Dis, 2018.PMID 30419968
  6. [8]Ameratunga R, Gillis D, Steele R. Diagnostic criteria for common variable immunodeficiency disorders. J Allergy Clin Immunol Pract, 2016.PMID 27587325
  7. [9]Lintner KE, Wu YL, Yang Y, et al. Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Front Immunol, 2016.PMID 26913032
  8. [10]Walport MJ. Complement. First of two parts. N Engl J Med, 2001.PMID 11287977
  9. [11]Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet, 2001.PMID 11528384